Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2016

01-01-2016 | Gastrointestinal Oncology

Incorporation of N0 Stage with Insufficient Numbers of Lymph Nodes into N1 Stage in the Seventh Edition of the TNM Classification Improves Prediction of Prognosis in Gastric Cancer: Results of a Single-Institution Study of 1258 Chinese Patients

Authors: Bofei Li, MD, Yuanfang Li, MD, Wei Wang, PhD, Haibo Qiu, PhD, Sharvesh Raj Seeruttun, MD, Cheng Fang, MD, Yongming Chen, MD, Yao Liang, MD, Wei Li, MD, Yingbo Chen, MD, Xiaowei Sun, MD, Yuanxiang Guan, MD, Youqing Zhan, MD, Zhiwei Zhou, MD

Published in: Annals of Surgical Oncology | Issue 1/2016

Login to get access

Abstract

Purpose

This study examined the prognosis of the “node-negative with eLNs ≤ 15” designation and the additional value of incorporating it into the pN1 designation in the seventh edition of the N classification.

Methods

From January 2000 to September 2010, a total of 1258 gastric cancer patients (patients with eLNs > 15 or node-negative with eLNs ≤ 15) undergoing radical gastric resection were enrolled in this study. We incorporated node-negative patients with eLNs ≤ 15 into pN1 and compared this designation with the current 7th edition UICC N stage for 3, 5-year overall survival by univariate and multivariate analysis. Homogeneity, discriminatory ability, and monotonicity of gradients in the hypothetical N stage and the UICC N stage were compared using linear trend χ2, likelihood ratio χ2 statistics, and Akaike information criterion (AIC) calculations.

Results

Node-negative patients with eLNs ≤ 15 had worse survival compared with those with eLNs > 15. In univariate and multivariate analyses, the hypothetical N stage showed superiority to the 7th edition pN staging. The hypothetical staging system had higher linear trend and likelihood ratio χ 2 scores and smaller AIC values compared with those for the TNM system, which represented the optimum prognostic stratification.

Conclusions

Node-negative patients with eLNs ≤ 15 can be considered to be incorporated into the pN1 stage in the 7th edition of the TNM classification.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.PubMedCrossRef Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.PubMedCrossRef
2.
go back to reference Xu D, Huang Y, Geng Q, et al. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PloS One. 2012;7(6):e38681.PubMedPubMedCentralCrossRef Xu D, Huang Y, Geng Q, et al. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PloS One. 2012;7(6):e38681.PubMedPubMedCentralCrossRef
3.
go back to reference Baiocchi GL, Tiberio GA, Minicozzi AM, et al. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252(1):70–3.PubMedCrossRef Baiocchi GL, Tiberio GA, Minicozzi AM, et al. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252(1):70–3.PubMedCrossRef
4.
go back to reference Jiao XG, Deng JY, Zhang RP, et al. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol. 2014;20(13):3640–8.PubMedPubMedCentralCrossRef Jiao XG, Deng JY, Zhang RP, et al. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol. 2014;20(13):3640–8.PubMedPubMedCentralCrossRef
5.
go back to reference Japanese Gastric Cancer A: Japanese classification of gastric carcinoma: 2nd English Edition. Gastric Cancer. 1998;1(1):10–24.CrossRef Japanese Gastric Cancer A: Japanese classification of gastric carcinoma: 2nd English Edition. Gastric Cancer. 1998;1(1):10–24.CrossRef
6.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM classification of malignant tumours, 7th edn. Chichester, NJ: Wiley; 2010. Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM classification of malignant tumours, 7th edn. Chichester, NJ: Wiley; 2010.
7.
go back to reference Harrell FE, Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA.1982;247(18):2543–6.PubMedCrossRef Harrell FE, Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA.1982;247(18):2543–6.PubMedCrossRef
8.
go back to reference Wunder JS, Healey JH, Davis AM, et al. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000;88(12):2721–30.PubMedCrossRef Wunder JS, Healey JH, Davis AM, et al. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000;88(12):2721–30.PubMedCrossRef
9.
go back to reference Kee KM, Wang JH, Lee CM, et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007;120(12):2650-5.PubMedCrossRef Kee KM, Wang JH, Lee CM, et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007;120(12):2650-5.PubMedCrossRef
10.
go back to reference Cho YK, Chung JW, Kim JK, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112(2):352–61.PubMedCrossRef Cho YK, Chung JW, Kim JK, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112(2):352–61.PubMedCrossRef
11.
go back to reference Hsu PK, Wu YC, Chou TY, et al. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg. 2010;89(4):1024-31.PubMedCrossRef Hsu PK, Wu YC, Chou TY, et al. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg. 2010;89(4):1024-31.PubMedCrossRef
12.
go back to reference Wang W, Xu DZ, Li YF, et al. Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection: results of a single-institution study of 1343 Chinese patients. Ann Oncol. 2011; 22(9):2049-56.PubMedCrossRef Wang W, Xu DZ, Li YF, et al. Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection: results of a single-institution study of 1343 Chinese patients. Ann Oncol. 2011; 22(9):2049-56.PubMedCrossRef
13.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.PubMedCrossRef Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.PubMedCrossRef
14.
go back to reference Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21.PubMedCrossRef Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21.PubMedCrossRef
Metadata
Title
Incorporation of N0 Stage with Insufficient Numbers of Lymph Nodes into N1 Stage in the Seventh Edition of the TNM Classification Improves Prediction of Prognosis in Gastric Cancer: Results of a Single-Institution Study of 1258 Chinese Patients
Authors
Bofei Li, MD
Yuanfang Li, MD
Wei Wang, PhD
Haibo Qiu, PhD
Sharvesh Raj Seeruttun, MD
Cheng Fang, MD
Yongming Chen, MD
Yao Liang, MD
Wei Li, MD
Yingbo Chen, MD
Xiaowei Sun, MD
Yuanxiang Guan, MD
Youqing Zhan, MD
Zhiwei Zhou, MD
Publication date
01-01-2016
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 1/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4578-0

Other articles of this Issue 1/2016

Annals of Surgical Oncology 1/2016 Go to the issue